AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 288: E1252-E1257, 2005. First published January 11, 2005; doi:10.1152/ajpendo.00279.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/E1252    most recent
00279.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Gómez, I.
Right arrow Articles by Vargas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Gómez, I.
Right arrow Articles by Vargas, F.

Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats

Isabel Rodríguez-Gómez,1 Rosemary Wangensteen,1 Juan Manuel Moreno,2 Virginia Chamorro,1 Antonio Osuna,2 and Félix Vargas1

1Facultad de Medicina, Departamento de Fisiología, Granada; and 2Servicio de Nefrología, Unidad Experimental, Hospital Virgen de las Nieves, Granada, Spain

Submitted 2 July 2004 ; accepted in final form 2 January 2005

We hypothesized that nitric oxide generated by inducible nitric oxide synthase (iNOS) may contribute to the homeostatic role of this agent in hyperthyroidism and may, therefore, participate in long-term control of blood pressure (BP). The effects of chronic iNOS inhibition by oral aminoguanidine (AG) administration on BP and morphological and renal variables in hyperthyroid rats were analyzed. The following four groups (n = 8 each) of male Wistar rats were used: control group and groups treated with AG (50 mg·kg–1·day–1, via drinking water), thyroxine (T4, 50 µg·rat–1·day–1), or AG + T4. All treatments were maintained for 3 wk. Tail systolic BP and heart rate (HR) were recorded weekly. Finally, we measured BP (mmHg) and HR in conscious rats and morphological, plasma, and renal variables. T4 administration produced a small BP (125 ± 2, P < 0.05) increase vs. control (115 ± 2) rats. AG administration to normal rats did not modify BP (109 ± 3) or any other hemodynamic variable. However, coadministration of T4 and AG produced a marked increase in BP (140 ± 3, P < 0.01 vs. T4). Pulse pressure and HR were increased in both T4- and T4 + AG -treated groups without differences between them. Plasma NOx (µmol/l) were increased in the T4 group (10.02 ± 0.15, P < 0.05 vs. controls 6.1 ± 0.10), and AG reduced this variable in T4-treated rats (6.81 ± 0.14, P < 0.05 vs. T4) but not in normal rats (5.78 ± 0.20). Renal and ventricular hypertrophy and proteinuria of hyperthyroid rats were unaffected by AG treatment. In conclusion, the results of the present paper indicate that iNOS activity may counterbalance the prohypertensive effects of T4.

blood pressure; aminoguanidine; thyroxine; rat



Address for reprint requests and other correspondence: F. Vargas, Facultad de Medicina, Departamento de Fisiología, E-18012 Granada, Spain (E-mail: fvargas{at}ugr.es)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Wangensteen, I. Rodriguez-Gomez, J. M. Moreno, M. Alvarez-Guerra, A. Osuna, and F. Vargas
Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1376 - R1382.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.